Poolbeg Pharma has obtained a South Korean patent for POLB 001, a treatment designed to prevent cytokine release syndrome (CRS), a serious side effect of cancer immunotherapy. The patent covers the use of p38 MAP kinase inhibitors to prevent CRS and is valid until 2044. This addition strengthens Poolbeg's international patent portfolio, which already includes patents in Europe and Australia. The company aims to make cancer immunotherapy safer and more accessible by enabling its use beyond specialist centers, potentially expanding the market for these treatments.
Poolbeg Pharma's recent South Korean patent for a cancer immunotherapy side effect treatment provides context for health sector activity. For readers following health stocks, here is Pluang's market snapshot as of Oct 06, 2026 14:12 WIB: out of 100 priced US health stocks, 69 rose and 27 fell. Notably, Adaptive Biotechnologies Corp (ADPT) rose 5.57% to USD 29.93 with a typical hold time of 36 days but saw 100% sell orders, while Teladoc Health Inc (TDOC) gained 4.35% to USD 5.76 with a 39-day hold time, and Revvity Inc (RVTY) increased 4.27% to USD 158.00 with a 12-day hold time.
Ethereum (ETH) maintained stability above $2,700, marking its first weekly close above this level in nine months, signaling renewed bullish sentiment. Treasury firm BitMine expanded its Ethereum holdings by 15,112 ETH, now controlling about 4.9% of t...
Bitcoin options markets have shifted toward a bullish stance, with one-week 25-delta call options now more in demand than puts, indicating traders expect price gains. This shift, first seen in August 2026, shows calls making up about 61.4% of open in...
Binance experienced a net outflow of approximately 40,000 Bitcoin over a 15-day period, reducing its reserves from 704,800 BTC to 663,100 BTC. The weekly net outflow hit 23,100 BTC, the highest since June 2023, with a daily peak of 14,300 BTC on Octo...
Nebius Group N.V. is rated a buy due to its strategic partnership with Palantir, which positions Nebius as the preferred sovereign infrastructure provider for Palantir's enterprise AI solutions targeting regulated industries. This collaboration allow...
Bango PLC has been chosen by South Korean telecom operator LG U+ to enhance subscription bundling on its Udok platform using Bango's Digital Vending Machine®. This partnership will enable LG U+ to quickly add global and local subscription services, o...
